We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTIC
12951
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$78K ﹤0.01%
31,200
+11,300
+57% +$27.1K
CEMI
12952
DELISTED
Chembio diagnostics, Inc.
CEMI
$78K ﹤0.01%
26,303
-14,440
-35% -$50.3K
PME
12953
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$78K ﹤0.01%
85,947
-30,153
-26% -$30.2K
BLRX
12954
CALL
BioLineRX
BLRX
$12M
$77K ﹤0.01%
+688
New +$80.9K
CETX icon
12955
Cemtrex
CETX
$5.2M
0
KPRX icon
12956
Kiora Pharmaceuticals
KPRX
$11.3M
$77K ﹤0.01%
59
+3
+5% +$4.66K
LPCN icon
12957
PUT
Lipocine
LPCN
$17.4M
$77K ﹤0.01%
3,253
-2,076
-39% -$48.8K
NHTC icon
12958
Natural Health Trends
NHTC
$15.5M
$77K ﹤0.01%
+11,049
New +$79.9K
PIM
12959
Franklin Master Intermediate Income Trust
PIM
$153M
$77K ﹤0.01%
18,389
-11,603
-39% -$49.1K
AIXC
12960
AIxCrypto Holdings Inc
AIXC
$13.7M
$77K ﹤0.01%
78
-374
-83% -$379K
RMTI icon
12961
Rockwell Medical
RMTI
$29.2M
$77K ﹤0.01%
774
+480
+163% +$49.5K
YJ
12962
Yunji
YJ
$9.21M
$77K ﹤0.01%
1,112
-600
-35% -$46K
JT
12963
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
$77K ﹤0.01%
29,074
+18,678
+180% +$50.3K
BIOC
12964
DELISTED
Biocept, Inc.
BIOC
$77K ﹤0.01%
+617
New +$83.5K
LCTX icon
12965
CALL
Lineage Cell Therapeutics
LCTX
$271M
$76K ﹤0.01%
26,500
+14,800
+126% +$38.3K
WYY icon
12966
WidePoint Corp
WYY
$93.4M
$76K ﹤0.01%
10,472
-2,576
-20% -$20.3K
FRTX
12967
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$76K ﹤0.01%
+1,786
New +$73.4K
CHRA
12968
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$76K ﹤0.01%
+1,505
New +$86.2K
CXAIW icon
12969
CXApp Inc Warrant
CXAIW
$765K
$75K ﹤0.01%
89,725
DRRX
12970
CALL
DELISTED
DURECT Corp
DRRX
$75K ﹤0.01%
+4,580
New +$79.9K
GOVX icon
12971
GeoVax Labs
GOVX
$3.74M
$75K ﹤0.01%
40
-161
-80% -$313K
JQC icon
12972
Nuveen Credit Strategies Income Fund
JQC
$708M
$75K ﹤0.01%
+11,065
New +$73.2K
IRD
12973
Opus Genetics
IRD
$300M
$75K ﹤0.01%
+14,257
New +$70.8K
QUMU
12974
DELISTED
Qumu Corp.
QUMU
$75K ﹤0.01%
25,911
+14,750
+132% +$72.5K
SMTS
12975
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$75K ﹤0.01%
24,960
-42,890
-63% -$142K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.